Please use this identifier to cite or link to this item: http://repositorio.unifesp.br/handle/11600/26264
Title: Molecular analysis in Brazilian cystic fibrosis patients reveals five novel mutations
Authors: Bernardino, ALF
Ferri, A.
Passos-Bueno, M. R.
Kim, CEA
Nakaie, CMA
Gomes, CET
Damaceno, N.
Zatz, M.
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Issue Date: 1-Mar-2000
Publisher: Mary Ann Liebert Inc Publ
Citation: Genetic Testing. Larchmont: Mary Ann Liebert Inc Publ, v. 4, n. 1, p. 69-74, 2000.
Abstract: We have performed molecular genetic analyses on 160 Brazilian patients diagnosed with cystic fibrosis (CF). Screening of mutations in 320 CF chromosomes was performed through single strand conformation polymorphism (SSCP) and heteroduplex analyses assay followed by DNA sequencing of the 27 exons and exon/intron boundaries of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. the frequency of CFTR variants of T-tract length of intron 8 (IVS8 Tn) was also investigated. This analysis enabled the detection of 232/320 CF mutations (72.2%) and complete genotyping of 61% of the patients. the Delta F508 mutation was found in 48.4% of the alleles, Another fifteen mutations (previously reported) mere detected: G542X, R1162X, N1303K, R334W, W1282X, G58E, L206W, R553X, 621+1G-->T, V232D, 1717-1G-->A, 2347 delG, R851L, 2789+5G-->A, and W1089X. Five novel mutations were identified, V201M (exon 6a), Y275X (exon 6b), 2686 insT (exon 14a), 3171 delC (exon 17a), and 3617 delGA (exon 19), These results contribute to the molecular characterization of CF in the Brazilian population. in addition, the identification of the novel mutation Y275X allowed prenatal diagnosis in a high-risk fetus.
URI: http://repositorio.unifesp.br/handle/11600/26264
ISSN: 1090-6576
Other Identifiers: http://dx.doi.org/10.1089/109065700316516
Appears in Collections:Artigo

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.